|
BilivistDrug - Bilivist The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Ipodate Sodium
Strength -
500MG
Applicant -
BERLEX
New Drug Application (NDA) Number -
087768
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Aug 11, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Berlex Inc
Bilivist
Optiray 300 64% Injectable; Injection
Optiray 320 68% Injectable; Injection Optiray 320 68% Injectable; Injection Optiray 350 74% Injectable; Injection Optiray 350 74% Injectable; Injection Hexabrix 39.3%;19.6% Injectable; Injection Oxilan-300 62% Injectable; Injection Oxilan-350 73% Injectable; Injection Oragrafin Calcium 3gm/packet Granule; Oral Bilivist 500mg Capsule; Oral NewDrugInformation |